Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure. [electronic resource]
- Kidney international Nov 1996
- 1718-25 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0085-2538
10.1038/ki.1996.491 doi
3',5'-Cyclic-AMP Phosphodiesterases--metabolism Animals Atrial Natriuretic Factor--pharmacology Cyclic GMP--metabolism Dogs Heart Failure--enzymology Hemodynamics--drug effects Hormones--blood In Vitro Techniques Isoenzymes--metabolism Kidney--drug effects Kidney Glomerulus--drug effects Male Nitroprusside--pharmacology Stimulation, Chemical Vasodilator Agents--pharmacology